# Cabergoline

NDC: 0093-5420
Generic name: Cabergoline
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20070307

FDA application: ANDA077750

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-5420"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-5420
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74b61e8a-7ae9-4996-85ec-df23c56de16f